This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Aug 1;158(8):863-864.

doi: 10.1001/jamadermatol.2022.2719.

Molluscum Contagiosum Therapeutics-New Options May Be Around the Corner

Affiliations

PMID: 35830172
DOI: 10.1001/jamadermatol.2022.2719

Comment

Molluscum Contagiosum Therapeutics-New Options May Be Around the Corner

Vikash S Oza. JAMA Dermatol. 2022.

. 2022 Aug 1;158(8):863-864.

doi: 10.1001/jamadermatol.2022.2719.

Author

Affiliation

¹ The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York.

PMID: 35830172
DOI: 10.1001/jamadermatol.2022.2719

No abstract available

PubMed Disclaimer

Comment on

Efficacy and Safety of Topical Nitric Oxide-Releasing Berdazimer Gel in Patients With Molluscum Contagiosum: A Phase 3 Randomized Clinical Trial.
Browning JC, Enloe C, Cartwright M, Hebert A, Paller AS, Hebert D, Kowalewski EK, Maeda-Chubachi T. Browning JC, et al. JAMA Dermatol. 2022 Aug 1;158(8):871-878. doi: 10.1001/jamadermatol.2022.2721. JAMA Dermatol. 2022. PMID: 35830173 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems